Notes in 13 Anticholinergic Drugs

To Subscribe, use this Key

Status	Last Update	Fields
Published	12/13/2023	{{c2::Cardiac}} cells have the {{c1::M2}} muscarinic receptor.
Published	12/13/2023	{{c2::Smooth muscle}} has the {{c1::M3}} muscarinic receptor.
Published	12/13/2023	{{c3::Anticholinergic::class}} drug ophthalmic effects include {{c1::mydriasis}} and {{c2::cycloplegia}}.
Published	12/13/2023	{{c1::Atropine}} is not commonly used as a antisialagogue because it may cause {{c2::tachycardia}}.
Published	12/13/2023	{{c3::Glycopyrrolate::anticholinergic}} cannot cross the blood-brain barrier because it is a {{c2::quaternary amine}}.
Published	12/13/2023	One advantage of glycopyrrolate over {{c2::scopolomine}} (in drying the upper airway) is that it does not produce {{c1::sedation}} or {{c1::amnesia}}.…
Published	12/13/2023	{{c1::Glycopyrrolate::glycopyrrolate or scopolamine}} increases the heart rate more than {{c1::scopolamine::glycopyrrolate or scopolamine}}.
Published	12/13/2023	Administration of scopolamine or atropine can cause {{c1::central anticholinergic syndrome}}, which manifests as delirium, red/dry/hot skin,…
Published	12/13/2023	Central anticholinergic syndrome can be treated with {{c1::physostigmine}}.
Published	12/13/2023	Anticholinergics can cause increased {{c1::intraocular pressure}} in patients with {{c2::glaucoma}}.
Status	Last Update	Fields